US Patent Issued to Genzyme on Jan. 20 for "Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS)" (Massachusetts, New Jersey, Georgia Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,776, issued on Jan. 20, was assigned to Genzyme Corp. (Cambridge, Mass.).

"Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS)" was invented by Oxana Ibraghimov-Beskrovnaya (Boston), Nikolay O. Bukanov (Boston), Herve Husson (Bridgewater, N.J.) and Sarah E. Moreno (Woodstock, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to a method of treating a ciliopathy in a subject, the method comprising administering to the subject an effective amount of a quinuclidine compound. Also disclosed is a pharmaceutical composition comprising a quinuclidine compound for use in said method."

The patent was filed ...